LDLR and acute myeloid leukemia: Based on its status as canonical SREBF1/2 target, it is not surprising that LDLR features among the robustly down‐regulated transcripts, (Figure S1A), thereby representing an unlikely contributor to the scavenging response, at least in our AML panel.